ImYoo closes seed round, grows team, and is on track to decentralize immune studies
ImYoo is on track to decentralize immune studies and kickstart research aimed at addressing actionable patient curiosities. We grew our...
top of page
Tatyana Dobreva
Sep 15, 2021
ImYoo partners with Illumina Accelerator to develop technology and launch immune studies
ImYoo was selected as part of a global cohort as part 13th funding cycle of Illumina Accelerator in the San Francisco Bay Area. Read the...
16 views0 comments
bottom of page